GluSense

Implantable Glucose Sensor for Continuous Data Transmission

Health Tech & Life Sciences
Non Active, Feb 2021 ceased to operate
Series C Rehovot, Israel Founded 2007
Last updated 2026-06-18
Total raised
$7.0M
Last: Grant 2017-02
Stage
Series C
Founded
2007
Headcount
3
HQ
Rehovot, Israel
Sector
Health Tech & Life Sciences

About

GluSense is developing Glyde CGM, a miniature, implantable, continuous glucose sensor. The sensor is designed to be implanted under the skin and can transmit continuous glucose values to an external unit or smartphone for over a year, significantly improving the quality of life for patients with diabetes. The sensor is composed of a sensing unit which detects glucose and provides a glucose-dependent optical signal using a biosensor, and a detection unit which reads the optical signals and transmits the data to the external unit. GluSense is part of the Rainbow Medical innovation house.

Funding history · 3 rounds · $7.0M total

2017-02
Grant $2.0M
2014-09
Date unknown
Undisclosed

Q&A

What is GluSense's primary product?
GluSense is developing Glyde CGM, a miniature, implantable, continuous glucose sensor designed to transmit continuous glucose values for over a year.
When was GluSense founded?
GluSense was founded in April 2007.
What is the current status of GluSense?
GluSense is currently inactive and ceased to operate in February 2021.
What is GluSense's total funding to date?
GluSense has raised a total of $7,000,000.
Which investors participated in GluSense's September 2014 funding round?
In September 2014, GluSense received funding from Ping An Ventures and ZTE-VC.
What was GluSense's most recent funding event?
GluSense received a grant of $2,000,000 in February 2017.
Who is the CEO of GluSense?
The CEO of GluSense is Boaz Brill.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical MonitorsDigital HealthcarePatient Remote Monitoring
Technologies
Platforms & InterfacesMobileSensingMaterials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcareProvidersPatients
Business model
B2BB2B2C

Highlights

1 PatentsVerified

Tags

digital-healthcaremedical-devicesdiabetessensorsmonitoringmhealthmobile-applicationsremote-monitoringhealthcare-providerschronic-patientsoptronicsmedical-technologiesbioconvergence
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)